weight loss plateau strategies glp-1 medication Some people taking drugs are concerned about muscle loss. In general, people with obesity have more muscle mass than people without obesity — simply because their bodies have to Evolving Considerations in Obesity Clinical

After treatment for 12 months, MDS-UPDRS Part III scores improved slightly by 0.04 points in the lixisenatide group and decreased by 3.04 points in the placebo group

Semaglutide medications release a hormone in our bodies that makes us feel full while eating (called GLP-1), causing people to eat less and therefore lose weight and lower their blood sugar levels, Dr

Gupta K, Raja A

And it does not appear to occur at the same rate across all GLP-1 medications and doses

The FDA's nutrition labeling guide emphasizes the importance of understanding ingredient lists

Cell Metabolism 2022: 10.1016/j.cmet.2022.07.002 receptor binding constants (GIP EC50 0.0643 nM, GLP-1 0.775 nM, glucagon 5.79 nM)